All Pharma News
Rezolute to Participate in Upcoming Investor Conferences

Rezolute to Participate in Upcoming Investor Conferences
GLOBENEWSWIRE
27 Aug 2024
Share Share
Rezolute`s IND For RZ358 Phase 3 Study Cleared By FDA

Rezolute`s IND For RZ358 Phase 3 Study Cleared By FDA
GLOBENEWSWIRE
05 Aug 2024
Share Share
Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Rezolute to Participate in the BTIG Virtual Biotechnology Conference
GLOBENEWSWIRE
31 Jul 2024
Share Share
Rezolute Announces Exercise of Underwriters’ Option to Purchase Addi Shares

Rezolute Announces Exercise of Underwriters’ Option to Purchase Addi Shares
GLOBENEWSWIRE
27 Jun 2024
Share Share
Rezolute Announces Proposed Public Offering of Stock and Pre-Funded Warrants

Rezolute Announces Proposed Public Offering of Stock and Pre-Funded Warrants
GLOBENEWSWIRE
13 Jun 2024
Share Share
Rezolute Prices $60M Public Offering Of Common Stock, Pre-Funded Warrants

Rezolute Prices $60M Public Offering Of Common Stock, Pre-Funded Warrants
GLOBENEWSWIRE
13 Jun 2024
Share Share
Rezolute to Participate in the Jefferies Global Healthcare Conference

Rezolute to Participate in the Jefferies Global Healthcare Conference
GLOBENEWSWIRE
30 May 2024
Share Share
Rezolute’s oral Eylea rival hits phase 2 goal, sending stock up

Rezolute’s oral Eylea rival hits phase 2 goal, sending stock up
Nick Paul Taylor FIERCE BIOTECH
22 May 2024
Share Share
Rezolute Reports Positive Topline Phase 2 RZ402 Data In DME

Rezolute Reports Positive Topline Phase 2 RZ402 Data In DME
GLOBENEWSWIRE
21 May 2024
Share Share
Rezolute Reports Q3 Fiscal 2024 Results, Business Update

Rezolute Reports Q3 Fiscal 2024 Results, Business Update
GLOBENEWSWIRE
15 May 2024
Share Share